Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century ...

TrialTranslator uses machine learning to assess cancer RCT generalizability, revealing survival gaps for high-risk patients ...

In the span of eight months, Big Pharma companies took over four of the hottest radiopharmaceutical players in the industry.

The latest announcement is out from GeneTether Therapeutics, Inc. ( ($TSE:GTTX) ). Rize Oncology, formerly GeneTether Therapeutics, has announced ...

Acquisition provides access to critical resources encompassing a biobank of more than 150,000 tumor specimens, 200,000 ...

In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial ...

Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a biotechnology company that designs and develops breakthrough ...

Each year, over 1.2 million Americans receive a cancer diagnosis, a journey that can be both overwhelming and daunting.

Kura Oncology ( ($KURA) ) has shared an update. Stephen Dale, M.D. resigned as Chief Medical Officer of Kura Oncology to ...

We recently compiled a list of the 12 Best Penny Stocks to Invest in According to the Media. In this article, we are going to ...

TD Cowen analyst Tyler Van Buren initiated coverage of CG Oncology (CGON) with a Buy rating and no price target The firm says cretostimogene ...

Combination creates immediate scientific synergies by harnessing complementary AI / ML platforms to improve patient outcomes across multiple ...